These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 25964531)

  • 21. Estrogen receptor beta polymorphism is associated with prostate cancer risk.
    Thellenberg-Karlsson C; Lindström S; Malmer B; Wiklund F; Augustsson-Bälter K; Adami HO; Stattin P; Nilsson M; Dahlman-Wright K; Gustafsson JA; Grönberg H
    Clin Cancer Res; 2006 Mar; 12(6):1936-41. PubMed ID: 16551880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A genetic score can identify men at high risk for prostate cancer among men with prostate-specific antigen of 1-3 ng/ml.
    Nordström T; Aly M; Eklund M; Egevad L; Grönberg H
    Eur Urol; 2014 Jun; 65(6):1184-90. PubMed ID: 23891454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergistic effect and VEGF/HSP70-hom haplotype analysis: relationship to prostate cancer risk and clinical outcome.
    Sfar S; Saad H; Mosbah F; Chouchane L
    Hum Immunol; 2010 Apr; 71(4):377-82. PubMed ID: 20096741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between lncrna PCGEM1 polymorphisms and prostate cancer risk.
    Xue Y; Wang M; Kang M; Wang Q; Wu B; Chu H; Zhong D; Qin C; Yin C; Zhang Z; Wu D
    Prostate Cancer Prostatic Dis; 2013 Jun; 16(2):139-44, S1. PubMed ID: 23459097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. E-cadherin polymorphisms and haplotypes influence risk for prostate cancer.
    Bonilla C; Mason T; Long L; Ahaghotu C; Chen W; Zhao A; Coulibaly A; Bennett F; Aiken W; Tullock T; Coard K; Freeman V; Kittles RA
    Prostate; 2006 Apr; 66(5):546-56. PubMed ID: 16372334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Germline Mutations in the Kallikrein 6 Region and Predisposition for Aggressive Prostate Cancer.
    Briollais L; Ozcelik H; Xu J; Kwiatkowski M; Lalonde E; Sendorek DH; Fleshner NE; Recker F; Kuk C; Olkhov-Mitsel E; Savas S; Hanna S; Juvet T; Hunter GA; Friedlander M; Li H; Chadwick K; Prassas I; Soosaipillai A; Randazzo M; Trachtenberg J; Toi A; Shiah YJ; Fraser M; van der Kwast T; Bristow RG; Bapat B; Diamandis EP; Boutros PC; Zlotta AR
    J Natl Cancer Inst; 2017 Apr; 109(4):. PubMed ID: 28376164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association analysis of Wnt pathway genes on prostate-specific antigen recurrence after radical prostatectomy.
    Huang SP; Ting WC; Chen LM; Huang LC; Liu CC; Chen CW; Hsieh CJ; Yang WH; Chang TY; Lee HZ; Bao BY
    Ann Surg Oncol; 2010 Jan; 17(1):312-22. PubMed ID: 19777185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostate Cancer Risk-Associated Single-Nucleotide Polymorphism Affects Prostate-Specific Antigen Glycosylation and Its Function.
    Srinivasan S; Stephens C; Wilson E; Panchadsaram J; DeVoss K; Koistinen H; Stenman UH; Brook MN; Buckle AM; Klein RJ; Lilja H; Clements J; Batra J;
    Clin Chem; 2019 Jan; 65(1):e1-e9. PubMed ID: 30538125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of CASP3 genetic polymorphisms rs1049216, rs2705897 and rs4647603 with the risk of prostate cancer in Galicia (NW Spain).
    López-Trigo N; Aguín N; Castuera IP; Rodríguez-Alonso A; Luis JR; Caeiro B
    Gene; 2018 Dec; 679():126-132. PubMed ID: 30176316
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of association between common variants at 17q12 and prostate cancer risk-evidence from Serbian population and meta--analysis.
    Nikolić ZZ; Branković AS; Savić-Pavićević DL; Preković SM; Vukotić VD; Cerović SJ; Filipović NN; Tomović SM; Romac SP; Brajušković GN
    Clin Transl Sci; 2014 Aug; 7(4):307-13. PubMed ID: 24422606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of genetic risk associated with prostate cancer using ancestry informative markers.
    Ricks-Santi LJ; Apprey V; Mason T; Wilson B; Abbas M; Hernandez W; Hooker S; Doura M; Bonney G; Dunston G; Kittles R; Ahaghotu C
    Prostate Cancer Prostatic Dis; 2012 Dec; 15(4):359-64. PubMed ID: 22801071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ICAM gene cluster SNPs and prostate cancer risk in African Americans.
    Chen H; Hernandez W; Shriver MD; Ahaghotu CA; Kittles RA
    Hum Genet; 2006 Aug; 120(1):69-76. PubMed ID: 16733712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Admixture Mapping Links RACGAP1 Regulation to Prostate Cancer in African Americans.
    Wilson BD; Ricks-Santi LJ; Mason TE; Abbas M; Kittles RA; Dunston GM; Kanaan YM
    Cancer Genomics Proteomics; 2018; 15(3):185-191. PubMed ID: 29695400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic variants in cell cycle control pathway confer susceptibility to aggressive prostate carcinoma.
    Kibel AS; Ahn J; Isikbay M; Klim A; Wu WS; Hayes RB; Isaacs WB; Daw EW
    Prostate; 2016 Apr; 76(5):479-90. PubMed ID: 26708993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polymorphisms in the prostate-specific antigen gene promoter do not predict serum prostate-specific antigen levels in African-American men.
    Beebe-Dimmer JL; Lange LA; Cain JE; Lewis RC; Ray AM; Sarma AV; Lange EM; Cooney KA
    Prostate Cancer Prostatic Dis; 2006; 9(1):50-5. PubMed ID: 16247489
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic Polymorphisms in IL-10 Promoter Are Associated With Smoking and Prostate Cancer Risk in African Americans.
    Abbas M; Mason T; Ibad A; Khraiwesh M; Apprey V; Kanaan Y; Wilson B; Dunston G; Ricks-Santi L; Brim H
    Anticancer Res; 2020 Jan; 40(1):27-34. PubMed ID: 31892550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lower prostate cancer risk in Swedish men with the androgen receptor E213 A-allele.
    Bentmar Holgersson M; Ruhayel Y; Karlsson M; Giwercman A; Bjartell A; Ohlsson C; Mellström D; Ljunggren Ö; Haghsheno MA; Damber JE; Lundberg Giwercman Y
    Cancer Causes Control; 2017 Mar; 28(3):227-233. PubMed ID: 28176139
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sequence variation in the mitochondrial gene cytochrome c oxidase subunit I and prostate cancer in African American men.
    Ray AM; Zuhlke KA; Levin AM; Douglas JA; Cooney KA; Petros JA
    Prostate; 2009 Jun; 69(9):956-60. PubMed ID: 19267350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between polymorphisms in cell cycle genes and advanced prostate carcinoma.
    Kibel AS; Jin CH; Klim A; Luly J; A Roehl K; Wu WS; Suarez BK
    Prostate; 2008 Aug; 68(11):1179-86. PubMed ID: 18459109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COX-2 promoter polymorphisms and the association with prostate cancer risk in South African men.
    Fernandez P; de Beer PM; van der Merwe L; Heyns CF
    Carcinogenesis; 2008 Dec; 29(12):2347-50. PubMed ID: 18974063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.